Sandbox g25: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) mNo edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
Line 82: | Line 82: | ||
</div> | </div> | ||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | [[Infectious Disease Project Antimicrobial Agents#Risk | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x6" style="cursor: pointer;>{{Fontcolor|#FFFFFF| ▸ Risk for TdP & QTc Prolongation}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x6"> | ||
---- | |||
[[Infectious Disease Project Antimicrobial Agents#Risk categories for antimicrobial agents known to have an association with TdP ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''TdP Risk Categories'''}}]] ● | |||
[[Infectious Disease Project Antimicrobial Agents#Torsades de pointes risk stratification schedules for antimicrobial agents ⇧ Return to Top ⇧ |{{Fontcolor|#FFFFFF|'''TdP Risk Stratification Schedules'''}}]] | |||
</div> | |||
|- | |- | ||
| style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle- | | style="padding: 1.5px 5px; background: #696969; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold; font-size: 10px;" | <div class="mw-customtoggle-x6" style="cursor: pointer;>{{Fontcolor|#FFFFFF| ▸ Interactions with CYP Isoenzymes}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-x6"> | ||
---- | ---- | ||
[[Infectious Disease Project Antimicrobial Agents#Substrates of Cytochrome P-450 Isozymes|{{Fontcolor|#FFFFFF|'''CYP Substrates'''}}]] ● | [[Infectious Disease Project Antimicrobial Agents#Substrates of Cytochrome P-450 Isozymes|{{Fontcolor|#FFFFFF|'''CYP Substrates'''}}]] ● |
Revision as of 08:11, 7 June 2015
Antimicrobial Agents |
---|
▸ Alphabetical List
|
▸ Categorical List Antibacterial Agents ● Antimycobacterial Agents ● Antifungal Agents ● Antiparasitic Agents ● Antiviral Agents ● Antiretroviral Agents Natural Penicillins ● Antistaphylococcal Penicillins ● Aminopenicillins ● Antipseudomonal Penicillins ● Carbapenems ● Monobactam ● Fluoroquinolones ● Cephalosporins – 1st Generation ● Cephalosporins – 2nd Generation ● Cephalosporins – 3rd and 4th Generation ● Aminoglycosides ● Lincosamides ● Macrolides ● Ketolide ● Tetracyclines ● Glycylcycline ● Glycopeptides ● Urinary Tract Agents ● Topical Antibacterials ● Polymyxins and Colistin ● Rifamycin ● Antifolates ● Fusidanes ● Oxazolidinones ● Nitroimidazoles ● Streptogramins |
▸ Generic & Pharmaceutical Names
|
▸ Pregnancy Risk Categories
|
▸ Risk for TdP & QTc Prolongation
|
▸ Interactions with CYP Isoenzymes
|